4.6 Review

Update on cognitive decline and dementia in elderly patients with diabetes

Journal

DIABETES & METABOLISM
Volume 40, Issue 5, Pages 331-337

Publisher

MASSON EDITEUR
DOI: 10.1016/j.diabet.2014.02.002

Keywords

Diabetes; Elderly patient; Cognitive impairment; Dementia; Hypoglycaemia

Funding

  1. Bristol-Myers Squibb
  2. Eli Lilly
  3. MSD
  4. Novo Nordisk
  5. Sanofi-Aventis
  6. Merck Serono
  7. Societe Francophone du Diabete (French-speaking Diabetes Society)
  8. national Programme Hospitalier de Recherche Clinique (PHRC
  9. Hospital Clinical Research Programme) grant

Ask authors/readers for more resources

Aim. - This article is an update of the relationship between type 2 diabetes (T2D), cognitive dysfunction and dementia in older people. Methods and results. - The number of older patients consulting for diabetes who also exhibit cognitive difficulties is consistently growing because of the increased longevity of the population as a whole and, according to a number of studies, the increased risk of cognitive impairment and dementia in older diabetic patients. Many studies have demonstrated a link between poor glucose control and deteriorated cognitive function in diabetic patients. A history of severe hypoglycaemic episodes has also been associated with a greater risk of late-in-life cognitive deficits and dementia in patients with T2D. Several processes are thought to promote cognitive decline and dementia in diabetics. Based on both clinical and non-clinical findings; the factors most likely to alter brain function and structure are cerebrovascular complications of diabetes, alterations in glucose and insulin, and recurrent hypoglycaemia. Together with other diabetes complications, cognitive deficits contribute to functional impairment, increased frequency of depression-related symptoms, greater incidence of recurrent hypoglycaemia, poorer adherence to treatment and, finally, poorer prognosis, as evidenced by recent longitudinal studies. Conclusion. - Clinical guidelines have recently been devised for older diabetic patients, particularly those with cognitive deficits and a reduced capacity to self-manage. In the most vulnerable patients, specific treatment strategies have been proposed for glycaemic control to limit metabolic decompensation and avoid the risk of hypoglycaemia. Educational measures, provided mainly to maintain patient autonomy and avoid hospital admission, have also been adapted according to patients' cognitive and functional status. (C) 2014 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available